Neogen (NEOG) Capital Expenditures Growth (3y) (2013 - 2026)
Neogen (NEOG) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 2.15% |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | -8.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -8.44% |
| Nov 30, 2025 | -1.22% |
| Aug 31, 2025 | 22.69% |
| May 31, 2025 | 8.68% |
| Feb 28, 2025 | 70.36% |
| Nov 30, 2024 | 63.30% |
| Aug 31, 2024 | 209.61% |
| May 31, 2024 | 49.09% |
| Feb 29, 2024 | 57.00% |
| Nov 30, 2023 | 52.80% |
| Aug 31, 2023 | 93.19% |
| May 31, 2023 | 48.87% |
| Feb 28, 2023 | 62.73% |
| Nov 30, 2022 | 24.08% |
| Aug 31, 2022 | 26.18% |
| May 31, 2022 | 65.14% |
| Feb 28, 2022 | 8.88% |
| Nov 30, 2021 | -6.38% |
| Aug 31, 2021 | -12.27% |
| May 31, 2021 | 16.33% |